Literature DB >> 22737962

Long-term quality of life in young adults treated for oral cavity squamous cell cancer.

Ligy Thomas1, Eric J Moore, Kerry D Olsen, Jan L Kasperbauer.   

Abstract

OBJECTIVES: We assessed the long-term quality of life (QOL) in patients who survived oral cavity squamous cell cancer when they were young and looked for any clinical factors that might adversely affect function and QOL.
METHODS: We performed a retrospective case series and questionnaire survey in a tertiary care center. The subjects were consecutive patients treated for oral cancers during a 25-year period, when they were 40 years of age or less. The patients completed the University of Washington Quality of Life questionnaire and the M. D. Anderson Dysphagia Inventory (MDADI). We made an overall descriptive report of swallowing and QOL measures in the study population and looked for any clinical factors associated with functional outcomes.
RESULTS: Among the 62 patients treated over the course of 25 years, 46 were alive and disease-free. Twenty-six participated. The median follow-up duration was 14.7 years (range, 3 to 27 years). Age at diagnosis and duration of follow-up did not correlate with overall QOL or health-related QOL. Seventy-seven percent rated their overall QOL as outstanding, very good, or good. The key domains affected by cancer were appearance, mood, saliva, and shoulder function. Radiotherapy significantly adversely affected the QOL. The median MDADI scores on all 4 subscales were at least 85%. Higher T-stage and radiotherapy were significantly associated with lower scores on all subscales.
CONCLUSIONS: The long-term health-related QOL in this cohort was quite good. Radiotherapy and tumor stage correlated with swallowing outcomes, and only radiotherapy seemed to adversely affect the overall QOL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22737962     DOI: 10.1177/000348941212100606

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  16 in total

1.  Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma.

Authors:  Daniel J Rohrbach; Nestor Rigual; Hassan Arshad; Erin C Tracy; Michelle T Cooper; Gal Shafirstein; Gregory Wilding; Mihai Merzianu; Heinz Baumann; Barbara W Henderson; Ulas Sunar
Journal:  J Biomed Opt       Date:  2016-01       Impact factor: 3.170

2.  Change in tongue pressure in patients with head and neck cancer after surgical resection.

Authors:  Yoko Hasegawa; Kazuma Sugahara; Tatsuyuki Fukuoka; Shota Saito; Ayumi Sakuramoto; Nobuhide Horii; Saori Sano; Kana Hasegawa; Yuta Nakao; Tomoki Nanto; Kanenori Kadoi; Kuniyasu Moridera; Kazuma Noguchi; Kazuhisa Domen; Hiromitsu Kishimoto
Journal:  Odontology       Date:  2017-02-14       Impact factor: 2.634

3.  Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.

Authors:  Christopher R Spencer; Hiram A Gay; Bruce H Haughey; Brian Nussenbaum; Douglas R Adkins; Tanya M Wildes; Todd A DeWees; James S Lewis; Wade L Thorstad
Journal:  Cancer       Date:  2014-08-20       Impact factor: 6.860

4.  PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs.

Authors:  Austin K Mattox; Jina Lee; William H Westra; Robert H Pierce; Ronald Ghossein; William C Faquin; Thomas J Diefenbach; Luc G Morris; Derrick T Lin; Lori J Wirth; Armida Lefranc-Torres; Eiichi Ishida; Patrick D Chakravarty; Lauren Johnson; Yang C Zeng; Huabiao Chen; Mark C Poznansky; Neil M Iyengar; Sara I Pai
Journal:  Cancer Res       Date:  2017-09-25       Impact factor: 12.701

5.  Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue.

Authors:  Dennis M Sopka; Tianyu Li; Miriam N Lango; Ranee Mehra; Jeffrey Chang-Jen Liu; Barbara Burtness; Douglas B Flieder; John A Ridge; Thomas J Galloway
Journal:  Oral Oncol       Date:  2013-09-17       Impact factor: 5.337

6.  Self-perception versus professional assessment of functional outcome after ablative surgery in patients with oral cancer.

Authors:  Benedicta E Beck-Broichsitter; Jörn Huck; Thomas Küchler; Daniela Hauke; Jürgen Hedderich; Jörg Wiltfang; Stephan T Becker
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-18       Impact factor: 4.553

7.  Do we reach the patients with the most problems? Baseline data from the WebCan study among survivors of head-and-neck cancer, Denmark.

Authors:  Trille Kjaer; Christoffer Johansen; Elo Andersen; Randi Karlsen; Anni Linnet Nielsen; Kirsten Frederiksen; Mikael Rørth; Susanne Oksbjerg Dalton
Journal:  J Cancer Surviv       Date:  2015-07-31       Impact factor: 4.442

8.  Swallow preservation exercises during chemoradiation therapy maintains swallow function.

Authors:  Victor M Duarte; Dinesh K Chhetri; Yuan F Liu; Andrew A Erman; Marilene B Wang
Journal:  Otolaryngol Head Neck Surg       Date:  2013-08-27       Impact factor: 3.497

9.  Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.

Authors:  Nestor Rigual; Gal Shafirstein; Michele T Cooper; Heinz Baumann; David A Bellnier; Ulas Sunar; Erin C Tracy; Daniel J Rohrbach; Gregory Wilding; Wei Tan; Maureen Sullivan; Mihai Merzianu; Barbara W Henderson
Journal:  Clin Cancer Res       Date:  2013-10-02       Impact factor: 12.531

10.  Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium.

Authors:  Tatiana Natasha Toporcov; Ariana Znaor; Zuo-Feng Zhang; Guo-Pei Yu; Deborah M Winn; Qingyi Wei; Marta Vilensky; Thomas Vaughan; Peter Thomson; Renato Talamini; Neonila Szeszenia-Dabrowska; Erich M Sturgis; Elaine Smith; Oxana Shangina; Stephen M Schwartz; Stimson Schantz; Peter Rudnai; Lorenzo Richiardi; Heribert Ramroth; Mark P Purdue; Andrew F Olshan; José Eluf-Neto; Joshua Muscat; Raquel Ajub Moyses; Hal Morgenstern; Ana Menezes; Michael McClean; Keitaro Matsuo; Dana Mates; Tatiana V Macfarlane; Jolanta Lissowska; Fabio Levi; Philip Lazarus; Carlo La Vecchia; Pagona Lagiou; Sergio Koifman; Kristina Kjaerheim; Karl Kelsey; Ivana Holcatova; Rolando Herrero; Claire Healy; Richard B Hayes; Silvia Franceschi; Leticia Fernandez; Eleonora Fabianova; Alexander W Daudt; Otávio Alberto Curioni; Luigino Dal Maso; Maria Paula Curado; David I Conway; Chu Chen; Xavier Castellsague; Cristina Canova; Gabriella Cadoni; Paul Brennan; Stefania Boccia; José Leopoldo Ferreira Antunes; Wolfgang Ahrens; Antonio Agudo; Paolo Boffetta; Mia Hashibe; Yuan-Chin Amy Lee; Victor Wünsch Filho
Journal:  Int J Epidemiol       Date:  2015-01-22       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.